Effects of LABAs on sleeping oxygen saturation in COPD

J. Verbraecken

Source: Breathe 2010; 7: 85
Journal Issue: September
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Verbraecken. Effects of LABAs on sleeping oxygen saturation in COPD. Breathe 2010; 7: 85

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Salmeterol improves sleeping oxygen saturation in COPD
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008

Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD
Source: Eur Respir J 2004; 23: 825-831
Year: 2004



Effects of supplemental oxygen and high-dose inhaled bronchodilator therapy in exercise performance and dyspnoea in patients with stable COPD
Source: Annual Congress 2004 - Exercise and systemic effects in COPD
Year: 2004


Multi-night continuous nocturnal oxygen saturation measurements in patients with COPD
Source: International Congress 2018 – Functional assessment of COPD
Year: 2018


Alterations in oxygen consumption during acute exacerbations of COPD
Source: International Congress 2018 – New methods and concepts in tests of lung and respiratory muscle function
Year: 2018

Effect of the increment of oxygen flow during sleep on COPD patients undergoing LTOT
Source: Eur Respir J 2003; 22: Suppl. 45, 275s
Year: 2003

Nocturnal hypercapnia and oxygen therapy in COPD patients
Source: Annual Congress 2008 - Pathophysiology of COPD
Year: 2008

Automatically adjusted oxygen flow rates to stabilize oxygen saturation during exercise in O2-dependent and hypercapnic COPD
Source: International Congress 2016 – Best abstracts in exercise capacity and testing in chronic lung diseases
Year: 2016


Effect of nocturnal oxygen therapy on daytime pulmonary hemodynamics in patients with COPD travelling to altitude. RCT.
Source: Virtual Congress 2021 – Treatments for airway diseases
Year: 2021


Benefits of long-term oxygen therapy among COPD patients with moderate resting desaturation
Source: International Congress 2019 – Clinical implications of COPD management
Year: 2019


Effect of heliox breathing on locomotor and respiratory muscle oxygen delivery during exercise in COPD patients with or without dynamic hyperinflation
Source: Annual Congress 2011 - Altered mechanisms during exercise in disease
Year: 2011


Effect of heliox on exercise capacity in COPD
Source: ERS Course 2017
Year: 2017

Effect of high dose oxygen on dyspnea and exercise tolerance in patients with COPD given LTOT
Source: Annual Congress 2007 - Effects of training in rehabilitation
Year: 2007


Effect of He-O2 breathing and inhaled salbutamol on expiratory flow limitation and dynamic hyperinflation in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 197s
Year: 2002

Effects of long-acting inhaled β-adrenergic and anticholinergic drugs on respiratory function and arterial blood gases in patients with COPD
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006


Does the degree of oxygen desaturation during exercise affect the response to ambulatory oxygen in COPD?
Source: Eur Respir J 2005; 26: Suppl. 49, 287s
Year: 2005

Effects of long-acting bronchodilators on changes of inspiratory capacity by hyperventilation in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 430s
Year: 2006

Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD
Source: Eur Respir J 2003; 21: 86-94
Year: 2003



The evaluation of home oxygen saturation for prediction of acute exacerbations of COPD.
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017

CPAP improves oxygen saturation and breathing rate in COVID-19 patients
Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond
Year: 2021